News | EP Lab | September 23, 2015

Societies Release New Guideline for Treating Supraventricular Tachycardia

Includes guidelines for diagnosis, referrals

guideline, treating supraventricular tachycardia, ACC, AHA, HRS

September 23, 2015 — A new guideline aimed at helping clinicians treat patients with supraventricular tachycardia, or a rapid heart rate, was released Sept. 23 by the American College of Cardiology, American Heart Association and Heart Rhythm Society.

Supraventricular tachycardia is common, with a prevalence of 2.29 per 1,000 persons in the general population. Those who have supraventricular tachycardia without any cardiovascular disease are usually younger compared to those who have cardiovascular disease. Women have twice the risk of developing the condition compared to men, and individuals over the age of 65 have five times the risk compared to younger individuals. Supraventricular tachycardia can impact quality of life depending on frequency, duration and whether symptoms occur not only when exercising but also while at rest. 

A diagnosis of supraventricular tachycardia is often made in the emergency department. A 12-lead electrocardiogram during tachycardia and sinus rhythm may help to determine the cause of tachycardia.

“The overall goal of the guideline is to provide clinicians with the tools needed to successfully diagnose and treat patients with supraventricular tachycardia upon presentation in the inpatient or outpatient setting,” said Richard L. Page, M.D., FACC, FAHA, FHRS, chair of the department of medicine at the University of Wisconsin and chair of the writing committee. “This includes quick diagnosis and treatment, making any necessary referrals to cardiology and electrophysiology specialists, discussion and collaboration with the patient, and the prescription of appropriate treatment.”

The guideline also aims to aid clinicians to help patients differentiate between supraventricular tachycardia and other disorders, such as panic attack, chest pain, and shortness of breath and syncope or near syncope— or a loss of consciousness due to a drop in blood pressure— that may cause similar symptoms.

The complete 2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia, was jointly published online in the Journal of the American College of Cardiology, Circulation, and HeartRhythm.

It is important to note that while atrial fibrillation is a supraventricular tachycardia, the term does not usually refer to atrial fibrillation. This guideline is for the management of all types of supraventricular tachycardia other than atrial fibrillation. Atrial fibrillation is addressed in the 2014 ACC/AHA/HRS Guideline for the Management of Atrial Fibrillation.

For more information: www.acc.org, www.heart.org, www.hrsonline.org


Related Content

News | EP Lab

April 22, 2025 — Orchestra BioMed Holdings, a biomedical company accelerating high-impact technologies to patients ...

Home April 29, 2025
Home
News | EP Lab

April 21, 2025 — Stereotaxis, a provider of surgical robotics for minimally invasive endovascular intervention, will ...

Home April 21, 2025
Home
News | EP Lab

Feb. 12, 2025 — Orchestra BioMed Holdings, a biomedical company accelerating high-impact technologies to patients ...

Home February 14, 2025
Home
News | EP Lab

July 31, 2024 — BioCardia, Inc., a developer of cellular and cell-derived therapeutics for the treatment of ...

Home July 31, 2024
Home
News | EP Lab

July 17, 2024 — BioCardia, Inc., a company focused on cellular and cell-derived therapeutics for the treatment of ...

Home July 17, 2024
Home
News | EP Lab

June 25, 2024 — Heart Hospital of New Mexico at Lovelace Medical Center (HHNM) and GE HealthCare (announced HHNM as the ...

Home June 25, 2024
Home
News | EP Lab

May 30, 2024 — Stereotaxis, a pioneer in surgical robotics for minimally invasive endovascular intervention, announced ...

Home May 30, 2024
Home
News | EP Lab

May 21, 2024 — Stereotaxis, a pioneer and global leader in surgical robotics for minimally invasive endovascular ...

Home May 21, 2024
Home
News | EP Lab

February 2, 2024 — GE HealthCare (Nasdaq: GEHC) announces the latest innovation in electrophysiology (EP), the Prucka 3 ...

Home February 02, 2024
Home
News | EP Lab

January 11, 2024 — It is with great sadness that the Diagnostic and Interventional Cardiology (DAIC) team has learned of ...

Home January 11, 2024
Home
Subscribe Now